122 related articles for article (PubMed ID: 37935608)
1. Pharmacist-led biometric screenings: A retrospective chart review in a community pharmacy.
Brown SA; Wensel TM; Smith W
Res Social Adm Pharm; 2024 Feb; 20(2):145-148. PubMed ID: 37935608
[TBL] [Abstract][Full Text] [Related]
2. Adoption of a biometric screening service in community pharmacies: a qualitative study.
Teeter BS; Braxton-Lloyd K; Armenakis AA; Fox BI; Westrick SC
J Am Pharm Assoc (2003); 2014; 54(3):258-66. PubMed ID: 24816352
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals.
Snella KA; Canales AE; Irons BK; Sleeper-Irons RB; Villarreal MC; Levi-Derrick VE; Greene RS; Jolly JL; Nelson AA
J Am Pharm Assoc (2003); 2006; 46(3):370-7. PubMed ID: 16739759
[TBL] [Abstract][Full Text] [Related]
6. Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk.
Newell BJ; Kells AM; Robertson AD; Braun TM; Ward KS; Rohling BJ; Melton BL
Kans J Med; 2023; 16():88-93. PubMed ID: 37124101
[TBL] [Abstract][Full Text] [Related]
7. Development and implementation of a pharmacist-managed university-based wellness center.
Berdine HJ; O'Neil CK
J Am Pharm Assoc (2003); 2007; 47(3):390-7. PubMed ID: 17510036
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
[TBL] [Abstract][Full Text] [Related]
9. Stakeholders' Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review.
El-Den S; Lee YLE; Gide DN; O'Reilly CL
Am J Prev Med; 2022 Oct; 63(4):636-646. PubMed ID: 35688723
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a pharmacy-based blood lead testing program: A retrospective analysis.
McMahon B; Fouts M; Klepser D; Klepser M
J Am Pharm Assoc (2003); 2023; 63(5):1628-1633. PubMed ID: 37169255
[TBL] [Abstract][Full Text] [Related]
11. Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.
Taylor S; Cairns A; Glass BD
BMJ Open; 2022 Apr; 12(4):e057011. PubMed ID: 35365533
[TBL] [Abstract][Full Text] [Related]
12. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support.
Darlow B; Brown M; Hudson B; Frew G; Clark J; Vincent L; Grainger R; Marra C; McKinlay E; Abbott JH; Briggs AM
Musculoskeletal Care; 2023 Mar; 21(1):3-15. PubMed ID: 35615979
[TBL] [Abstract][Full Text] [Related]
13. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
Maulavizada H; Emmerton L; Hattingh HL
BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care screenings at the University of Minnesota: mechanism for civic engagement.
Palombi LC; Bastianelli K; Stratton T
J Am Pharm Assoc (2003); 2014; 54(1):56-62. PubMed ID: 24407741
[TBL] [Abstract][Full Text] [Related]
15. What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy.
Nielsen S; Sanfilippo P; Picco L; Bruno R; Kowalski M; Wood P; Larney S
Int J Clin Pharm; 2021 Apr; 43(2):420-429. PubMed ID: 32533428
[TBL] [Abstract][Full Text] [Related]
16. Caregiver in Alzheimer's disease, pharmacist, and pharmacy technician attitudes and knowledge about caregiver burden screening in community pharmacies.
Novais T; Chomel M; Dauphinot V; Mouchoux C
Ann Pharm Fr; 2020 May; 78(3):199-205. PubMed ID: 32037030
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of community pharmacy service mix: evidence from the 2004 National Pharmacist Workforce Study.
Doucette WR; Kreling DH; Schommer JC; Gaither CA; Mott DA; Pedersen CA
J Am Pharm Assoc (2003); 2006; 46(3):348-55. PubMed ID: 16739756
[TBL] [Abstract][Full Text] [Related]
18. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
Januszka J; Notarianni V; Devenny E; Harris E
J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of a community pharmacy-based health and wellness introductory pharmacy practice experience.
McDowell L; Helmer R; Stevenson TL; Sierko A; Braxton Lloyd K
J Am Pharm Assoc (2003); 2022; 62(1):63-70. PubMed ID: 34756690
[TBL] [Abstract][Full Text] [Related]
20. Use of a service evaluation and lean thinking transformation to redesign an NHS 111 refer to community Pharmacy for Emergency Repeat Medication Supply Service (PERMSS).
Nazar H; Nazar Z; Simpson J; Yeung A; Whittlesea C
BMJ Open; 2016 Aug; 6(8):e011269. PubMed ID: 27566629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
